KLF3 and breast carcinoma: On the other hand, the decreased levels of KLF3 in breast cancer, acute myeloid leukemia, and osteosarcoma, and is thus linked to an inferior prognosis in breast cancer [32], acute myeloid leukemia [33] and osteosarcoma [34].